Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-026093
Filing Date
2023-04-28
Accepted
2023-04-28 17:59:12
Documents
1
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4028
  Complete submission text file 0001209191-23-026093.txt   5509
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40505 | Film No.: 23868903

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Issuer) CIK: 0001836056 (see all company filings)

EIN.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)